Initial observations suggested that C-C motif chemokines exclusively mediate chemotaxis of mononuclear cells. In addition, recent studies also implicated these chemotactic cytokines in the recruitment of neutrophils. The underlying mechanisms remained largely unknown. Using in vivo microscopy on the mouse cremaster muscle, intravascular adherence and subsequent paracellular transmigration of neutrophils elicited by the chemokine (C-C motif) ligand 3 (CCL3, synonym MIP-1α) were significantly diminished in mice with a deficiency of the chemokine (C-C motif) receptor 1 (Ccr1−/−) or 5 (Ccr5−/−). Using cell-transfer techniques, neutrophil responses required leukocyte CCR1 and nonleukocyte CCR5. Furthermore, neutrophil extravasation elicited by CCL3 was almost completely abolished on inhibition of G protein–receptor coupling and PI3Kγ-dependent signaling, while neutrophil recruitment induced by the canonical neutrophil attractants chemokine (C-X-C motif) ligand 1 (CXCL1, synonym KC) or the lipid mediator platetelet-activating factor (PAF) was only partially reduced. Moreover, Ab blockade of β2 integrins, of α4 integrins, or of their putative counter receptors ICAM-1 and VCAM-1 significantly attenuated CCL3-, CXCL1-, or PAF-elicited intravascular adherence and paracellular transmigration of neutrophils. These data indicate that the C-C motif chemokine CCL3 and canonical neutrophil attractants exhibit both common and distinct mechanisms for the regulation of intravascular adherence and transmigration of neutrophils.

Leukocyte recruitment from the microvasculature to the site of inflammation is a hallmark in the inflammatory response. This highly regulated multistep process requires the coordinated interplay of chemoattractants, signaling molecules, and adhesion receptors ultimately controlling intravascular rolling and firm adherence as well as transmigration of leukocytes to the inflamed tissue.1,,4  Although the general principles of leukocyte extravasation have been studied in detail in the past decades, the mechanisms underlying subtype-specific leukocyte responses remain incompletely understood.

Chemokines are small molecules (8-14 kDa) which can be classified into C, C-C, C-X-C, and C-X3-C motif chemokines according to the arrangement of their N-terminal cysteine residues. Interaction of chemokines with specific G protein–coupled chemokine receptors is thought to activate intracellular signaling pathways ultimately mediating adhesion and directed migration of leukocytes.5,7 

According to our current knowledge, spatiotemporal expression patterns of chemokines, as well as expression of specific chemokine receptors on different leukocyte subtypes, are suggested to enable the guidance of defined leukocyte subsets to the site of inflammation. In this context, neutrophils are thought to be attracted by C-X-C motif chemokines (eg, CXCL1/KC, CXCL2/MIP-2), whereas C-C motif chemokines (eg, CCL3/MIP-1α) are supposed to primarily mediate the migration of mononuclear cells.3,5,7  In addition to this well-known function, however, there is increasing evidence that C-C motif chemokines are also involved in the migration of granulocytes including eosinophils,8,9  basophils,10,11  and, in particular, neutrophils.12,,,16  These reports reveal a previously unrecognized role of these chemotactic cytokines in the inflammatory response. The exact mechanisms underlying neutrophil recruitment by C-C motif chemokines are still unknown.

Recently, C-C motif chemokine receptors including CCR1 and CCR5 have been identified on the surface of neutrophils.17,,,,22  Notably, these chemokine receptors are also present on a variety of resident cell populations known to promote extravasation of neutrophils such as endothelial cells,23,24  smooth muscle cells,25  or mast cells.26,27  The relative contribution of these receptors to the recruitment of neutrophils has not yet been investigated. Moreover, the relevant signaling and adhesion events involved in C-C motif chemokine-dependent neutrophil responses are largely unexplored.

Here, we demonstrate that CCL3-dependent intravascular firm adherence and subsequent paracellular transmigration of neutrophils require both C-C motif chemokine receptor CCR1 and CCR5. In this context, leukocyte CCR1 and nonleukocyte CCR5 are engaged regulating C-C motif chemokine-dependent neutrophil responses via G protein–receptor coupling as well as PI3Kγ-dependent signaling pathways. As a consequence, firm adherence to the vascular endothelium is particularly mediated by the β2 integrins lymphocyte function-associated Ag-1 (CD11a/LFA-1) and macrophage-1 Ag (CD11b/Mac-1), to a lesser degree by α4 integrins (α4β1 integrin/VLA-4 and/or α4β7 integrin) as well as by their (putative) counter receptors intercellular adhesion molecule-1 (CD54/ICAM-1) and vascular cell adhesion molecule-1 (CD106/VCAM-1), whereas subsequent paracellular transmigration of neutrophils is facilitated through platelet/endothelial cell adhesion molecule-1 (CD31/PECAM-1) and intercellular adhesion molecule-2 (CD102/ICAM-2).

Animals

BALB/cAnNCrl (briefly BALB/c) mice were obtained from Charles River. Ccr1-deficient mice (Ccr1tm1Gao) and Ccr5-deficient mice (Ccr5tm1Blck) have been generated as described28,29  and backcrossed for 10 (Ccr1) or 13 generations (Ccr5) to the BALB/c background. Experiments were performed exclusively with male mice at the age of 20 ± 5 weeks. Mice were raised in individually ventilated cages under specific pathogen-free conditions and housed during the experiments under conventional conditions with free access to food and water. All experiments were performed in compliance with the German legislation for the protection of animals and were approved by the Regierung von Oberbayern (government of Upper Bavaria).

Musculus cremaster assay

The surgical preparation of the cremaster muscle was performed as originally described by Baez with minor modifications.30,31  Mice were anesthetized using a ketamine/xylazine mixture (100 mg/kg ketamine and 10 mg/kg xylazine), administrated by IP injection. The left femoral artery was cannulated in a retrograde manner for administration of microspheres and drugs (see “Quantification of leukocyte kinetics and microhemodynamic parameters”). The right cremaster muscle was exposed through a ventral incision of the scrotum. The muscle was opened ventrally in an avascular zone, using careful electrocautery to stop any bleeding, and spread over the transparent pedestal of a custom-made microscopy stage. Epididymis and testicle were detached from the cremaster muscle and placed into the abdominal cavity. Throughout the procedure as well as after surgical preparation during in vivo microscopy, the muscle was superfused with warm-buffered saline.

In vivo microscopy

The setup for in vivo microscopy was centered around an Olympus BX 50 upright microscope (Olympus Microscopy), equipped for stroboscopic fluorescence epiillumination microscopy. Light from a 75-W xenon source was narrowed to a near-monochromatic beam of a wavelength of 700 nm by a galvanometric scanner (Polychrome II; TILL Photonics) and directed onto the specimen via a FITC filter cube equipped with dichroic and emission filters (DCLP 500, LP515; Olympus). Microscopy images were obtained with Olympus water immersion lenses (20×/numerical aperture [NA] 0.5 and 10×/NA 0.3) and recorded with an analog black-and-white charge-coupled device video camera (Cohu) and an analog video recorder (Panasonic). Oblique illumination was obtained by positioning a mirroring surface (reflector) directly below the specimen and tilting its angle relative to the horizontal plane. The reflector consisted of a round cover glass (thickness, 0.19-0.22 mm; diameter, 11.8 mm), which was coated with aluminum vapor (Freichel) and brought into direct contact with the overlying specimen as described previously.31  For measurement of centerline blood flow velocity, green fluorescent microspheres (2-μm diameter; Molecular Probes) were injected via the femoral artery catheter, and their passage through the vessels of interest was recorded using the FITC filter cube under appropriate stroboscopic illumination (exposure, 1 ms; cycle time, 10 ms; λ = 488 nm), integrating video images for sufficient time (> 80 ms) to allow for the recording of several images of the same bead on one frame. Beads that were flowing freely along the centerline of the vessels were used to determine blood flow velocity (see next section).

Quantification of leukocyte kinetics and microhemodynamic parameters

For offline analysis of parameters describing the sequential steps of leukocyte extravasation, we used the Cap-Image image analysis software (Dr Zeintl). Rolling leukocytes were defined as those moving slower than the associated blood flow and quantified as described previously. Firmly adherent cells were determined as those resting in the associated blood flow for > 30 seconds and related to the luminal surface per 100-μm vessel length. Transmigrated cells were counted in regions of interest (ROI), covering 75 μm on both sides of a vessel over 100-μm vessel length. By measuring the distance between several images of one fluorescent bead under stroboscopic illumination, centerline blood flow velocity was determined. From measured vessel diameters and centerline blood flow velocity, apparent wall shear rates were calculated, assuming a parabolic flow velocity profile over the vessel cross-section.

Quantification of fluorescent leukocyte responses

To investigate the contribution of leukocyte and nonleukocyte target proteins to CCL3-elicited leukocyte responses, a cell-transfer technique was used as described previously.32,33  Briefly, bone marrow leukocytes were isolated from donor mice by flushing the femur and tibia bones with PBS. Cells were then sieved and counted, resuspended in PBS containing BSA (0.25%), and incubated with calcein-AM (Molecular Probes; 10μM final concentration at 37°C for 30 minutes) as well as in separate experiments also with pertussis toxin (PTx), wortmannin, or drug vehicle. After 2 washes, the cells were injected intravenously into recipient mice via the right jugular vein (107 cells/mouse) 120 minutes before the surgical preparation. Fluorescent cells were counted in 175 high-power fields (HPF) per animal, this being equivalent to the total quantifiable area of an exteriorized cremaster muscle in the present studies. Results are shown as the number of adherent or transmigrated calcein-labeled cells/HPF.

Reagents

A nonblocking Alexa Fluor 488–conjugated anti–PECAM-1 mAb (clone 390; 40 μg/mL, applied into the superfusion solution; BioLegend) was used to delineate endothelial junctions. Clodronate liposomes (injection into the tail vein 48 hours [200 μL], 24 hours [100 μL], and 6 hours [100 μL] before the experiment; VUmc FdG) were prepared as described elsewhere and used to deplete monocytes and macrophages according to previous protocols.34,35  Recombinant murine CCL3, CXCL1 (300 ng in 0.4 mL of PBS; intrascrotally; R&D Systems), or platelet-activating factor (PAF; 0.4 mL of 10−6M solution, intrascrotally; Sigma-Aldrich) were used to induce leukocyte extravasation. Blocking anti–LFA-1 mAb (clone M17/4), anti–Mac-1 mAb (clone M1/70), anti-α4 integrin mAbs (blocking α4β1 integrin/VLA-4 and α4β7 integrin; clone R1-2 and clone PS/2), anti–PECAM-1 mAb (clone MEC 13.3), anti–ICAM-1 mAb (clone YN1), anti–ICAM-2 mAb (clone 3C4), and anti–VCAM-1 mAb (clone 429; 50 μg in 150 μL of saline, i.a.; BioLegend) were used to inhibit interactions with the respective adhesion molecules, and the nonblocking anti–PECAM-1 mAb (clone 390; 50 μg in 150 μL of saline, intra-arterially; BioLegend) was used as additional control. PTx (4 μg in 150 μL of saline, intra-arterially; Sigma-Aldrich) was used to inhibit G protein–receptor coupling. Wortmannin (irreversible pan-PI3K inhibitor; 1 mg/kg BW, intra-arterially; Sigma-Aldrich), PI103 (reversible pan-PI3K inhibitor; 3 × 5 mg/kg BW intraperitoneally), AS605240 (reversible PI3Kγ inhibitor; 3 × 5 mg/kg BW IP), and IC87114 (reversible PI3Kδ inhibitor; 3 × 5 mg/kg BW intraperitoneally) were used to inhibit PI3K activity.

Experimental groups

Animals were assigned randomly to the following groups: PBS-treated wild-type (WT) control mice as well as WT, Ccr1−/−, and Ccr5−/− mice undergoing intrascrotal stimulation with murine recombinant CCL3 (180 minutes; n = 6). Moreover, leukocyte responses were analyzed in the cremaster muscle of WT mice receiving fluorescent leukocytes from WT, Ccr1−/−, or Ccr5−/− donors as well of Ccr1−/− and of Ccr5−/− mice receiving fluorescent leukocytes from WT donors undergoing intrascrotal stimulation with CCL3 (180 minutes; n = 7 each group). Leukocyte responses were also analyzed in the cremaster muscle of WT mice treated with PTx, wortmannin, or drug vehicle receiving fluorescent leukocytes from WT mice coincubated with PTx, wortmannin, or drug vehicle undergoing intrascrotal stimulation with CCL3 (180 minutes; n = 4 each group).

In addition, experiments were conducted in PBS-treated WT control mice as well as in WT mice treated with PTx, with PI3K inhibitors PI103, AS605240, IC87114, with an anti–LFA-1 mAb, an anti–Mac-1 mAb, anti-α4 integrin mAbs (clone R1-2 and clone PS/2), anti–PECAM-1 mAbs (clone Mec13.3 and clone 390), an anti–ICAM-1 mAb, an anti–ICAM-2 mAb, an anti–VCAM-1 mAb, or with a respective isotype control Ab/drug vehicle undergoing intrascrotal stimulation with CCL3, CXCL1, or PAF (180 minutes; n = 4 each group). Furthermore, experiments were performed in WT animals receiving clodronate liposomes or control PBS liposomes undergoing intrascrotal stimulation with CCL3, CXCL1, or PAF (180 minutes; n = 4 each group). Finally, leukocyte transmigration routes were analyzed in the cremaster muscle of WT animals receiving a nonblocking Alexa Fluor 488–conjugated anti–PECAM-1 mAb (clone 390) undergoing intrascrotal stimulation with CCL3, CXCL1, or PAF (180 minutes; n = 3 each group).

Experimental protocols

For the analysis of CCL3-, CXCL1-, and PAF-dependent leukocyte responses, leukocyte recruitment to the cremaster muscle was induced by intrascrotal injection of recombinant murine CCL3, CXCL1, or PAF. After 180 minutes, 5 vessel segments were randomly chosen in a central area of the spread-out cremaster muscle among those that were at least 150 μm away from neighboring postcapillary venules and did not branch over a distance of at least 150 μm. Abs/inhibitors were applied 5 minutes before the intrascrotal injection of inflammatory mediators (see “Reagents”). After having obtained recordings of migration parameters, blood flow velocity was determined as described in “Quantification of leukocyte kinetics.” After in vivo microscopy, tissue samples of the cremaster muscle were taken for immunohistochemistry (see supplemental Methods, available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Blood samples were collected by cardiac puncture for the determination of systemic leukocyte counts using a Coulter ACT counter (Coulter Corp). Anesthetized animals were then killed by bleeding to death.

Statistics

Data analysis was performed with a statistical software package (SigmaStat for Windows; Jandel Scientific). The ANOVA on ranks test followed by the Student-Newman-Keuls test was used for the estimation of stochastic probability in intergroup comparisons. Mean values and SEM are given. P values < .05 were considered significant.

Mouse gene nomenclature

The officially approved gene symbols from the Mouse Genome Informatics Database are used throughout this report.

Role of CCR1 and CCR5 in CCL3-elicited leukocyte responses

Using near-infrared transillumination in vivo microscopy, the role of the chemokine receptors CCR1 and CCR5 for chemokine-dependent rolling, firm adherence, and transmigration of leukocytes were analyzed in the mouse cremaster muscle 3 hours after intrascrotal injection of CCL3 (Figure 1A).

Figure 1

Role of CCR1 and CCR5 for CCL3-elicited leukocyte responses. (A) Representative RLOT in vivo microscopy images of postcapillary venules in WT, Ccr1-, and Ccr5-deficient mice after stimulation with CCL3 (scale bar: 20 μm). Leukocyte intravascular firm adherence and transmigration were quantified in postcapillary venules of the cremaster muscle as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” (B-C) Results for PBS-treated WT control mice as well as for WT, Ccr1-, and Ccr5-deficient mice after stimulation with CCL3 (mean ± SEM for n = 6 per group; #P < .05, vs unstimulated; *P < .05, vs WT). (D) Intravascular adherence and (E) transmigration of fluorescence-labeled bone marrow leukocytes were quantified in the cremaster muscle using in vivo fluorescence microscopy as detailed in “Quantification of florescent leukocyte responses.” Panels show results for WT mice receiving leukocytes from WT, Ccr1-, or Ccr5-deficient donors as well as for Ccr1- and Ccr5-deficient mice receiving leukocytes from WT donors after stimulation with CCL3 (mean ± SEM for n = 7 per group; #P < .05, vs unstimulated; *P < .05, vs WT→WT).

Figure 1

Role of CCR1 and CCR5 for CCL3-elicited leukocyte responses. (A) Representative RLOT in vivo microscopy images of postcapillary venules in WT, Ccr1-, and Ccr5-deficient mice after stimulation with CCL3 (scale bar: 20 μm). Leukocyte intravascular firm adherence and transmigration were quantified in postcapillary venules of the cremaster muscle as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” (B-C) Results for PBS-treated WT control mice as well as for WT, Ccr1-, and Ccr5-deficient mice after stimulation with CCL3 (mean ± SEM for n = 6 per group; #P < .05, vs unstimulated; *P < .05, vs WT). (D) Intravascular adherence and (E) transmigration of fluorescence-labeled bone marrow leukocytes were quantified in the cremaster muscle using in vivo fluorescence microscopy as detailed in “Quantification of florescent leukocyte responses.” Panels show results for WT mice receiving leukocytes from WT, Ccr1-, or Ccr5-deficient donors as well as for Ccr1- and Ccr5-deficient mice receiving leukocytes from WT donors after stimulation with CCL3 (mean ± SEM for n = 7 per group; #P < .05, vs unstimulated; *P < .05, vs WT→WT).

Close modal

It is well known that surgical preparation of the cremaster muscle induced leukocyte rolling in postcapillary venules. No significant differences were observed in numbers of rolling leukocytes among all experimental groups (data not shown).

In contrast, the number of firmly adherent leukocytes (11.6 ± 1.9 μm2) was significantly increased on stimulation with CCL3 compared with PBS-treated control animals (4.3 ± 0.9 μm2). This increase was almost completely abolished in animals lacking the chemokine receptor Ccr1 (6.1 ± 1.4 μm2) or Ccr5 (6.3 ± 1.5 μm2; Figure 1B).

Moreover, there was a significant elevation in numbers of transmigrated leukocytes (22.5 ± 2.9 μm2) in response to CCL3 compared with controls (4.9 ± 0.8 μm2). This elevation was significantly attenuated in Ccr1−/− (11.5 ± 2.3 μm2) and Ccr5−/− (9.6 ± 1.3 μm2) animals (Figure 1C).

Role of leukocyte versus nonleukocyte CCR1 and CCR5 in CCL3-elicited leukocyte responses

To enable investigations into the contributions of leukocyte and nonleukocyte chemokine receptors in CCL3-elicited leukocyte responses, bone marrow leukocytes were isolated from WT, Ccr1−/−, or Ccr5−/− donor mice, fluorescently labeled with calcein AM, and injected intravenously into WT, Ccr1−/−, or Ccr5−/− recipient mice. Three hours after intrascrotal injection of CCL3, the number of fluorescent cells adherent or transmigrated was quantified in the cremaster muscle by in vivo fluorescence microscopy.

In unstimulated control mice, only a few fluorescent cells were found attached to the wall of the postcapillary venules (0.14 ± 0.03/HPF) or within the perivascular tissue (0.12 ± 0.02/HPF). In contrast, stimulation with CCL3 caused a significant elevation in numbers of adherent (0.84 ± 0.11/HPF; Figure 1D) and transmigrated (0.86 ± 0.17/HPF; Figure 1E) fluorescent cells. This elevation in the number of adherent and transmigrated fluorescent cells was significantly diminished in WT animals receiving Ccr1−/− cells (0.42 ± 0.09/HPF; 0.31 ± 0.06/HPF) as well as in Ccr5−/− animals receiving WT cells (0.44 ± 0.06/HPF; 0.45 ± 0.10/HPF), respectively.

Role of G protein–receptor coupling and PI3K activation for CCL3-elicited leukocyte responses

Interaction of chemokines to their cognate receptors is supposed to activate intracellular G proteins. To explore the functional relevance of these processes for CCL3-elicited leukocyte responses, another series of experiments was performed. Using reflected light oblique transillumination (RLOT) in vivo microscopy, CCL3-elicited intravascular firm adherence and (subsequent) transmigration of leukocytes were nearly abolished in animals treated with PTx (a compound blocking G protein– receptor coupling; Figure 2A-B), whereas leukocyte rolling was not significantly altered (data not shown). Furthermore, treatment with a reversible pan-PI3K inhibitor or a specific PI3Kγ inhibitor, but not with a PI3Kδ inhibitor, almost completely abrogated CCL3-elicited leukocyte responses (Figure 2C-D). Using a cell transfer technique, we found that stimulation with CCL3 caused a significant increase in the numbers of adherent and transmigrated fluorescent cells compared with controls (Figure 2E). This increase was almost completely abolished in animals treated systemically with PTx or the irreversible pan-PI3K inhibitor wortmannin as well as in animals receiving WT donor cells pretreated with PTx or wortmannin.

Figure 2

Role of G protein–receptor coupling and PI3K for CCL3-elicited leukocyte responses. (A,C) Leukocyte firm adherence, and (B,D) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving PTx, the PI3K inhibitors PI103 (pan-PI3K), AS605240 (PI3Kγ), and IC87114 (PI3Kδ), or respective drug vehicle after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs vehicle). (E) Intravascular adherence and transmigration of fluorescence-labeled bone marrow leukocytes were quantified in the cremaster muscle using in vivo fluorescence microscopy as detailed in “Quantification of florescent leukocyte responses.” Panels show results for WT mice treated with PTx, the irreversible PI3K inhibitor wortmannin, or drug vehicle receiving leukocytes from WT donors pretreated with PTx, wortmannin, or drug vehicle after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs WT→WT + drug vehicle).

Figure 2

Role of G protein–receptor coupling and PI3K for CCL3-elicited leukocyte responses. (A,C) Leukocyte firm adherence, and (B,D) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving PTx, the PI3K inhibitors PI103 (pan-PI3K), AS605240 (PI3Kγ), and IC87114 (PI3Kδ), or respective drug vehicle after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs vehicle). (E) Intravascular adherence and transmigration of fluorescence-labeled bone marrow leukocytes were quantified in the cremaster muscle using in vivo fluorescence microscopy as detailed in “Quantification of florescent leukocyte responses.” Panels show results for WT mice treated with PTx, the irreversible PI3K inhibitor wortmannin, or drug vehicle receiving leukocytes from WT donors pretreated with PTx, wortmannin, or drug vehicle after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs WT→WT + drug vehicle).

Close modal

Role of β2 and α4 integrins as well as of ICAM-1, ICAM-2, VCAM-1, and PECAM-1 in CCL3-elicited leukocyte responses

In a next step, candidate adhesion molecules involved in the leukocyte recruitment process were analyzed for their functional relevance in CCL3-dependent leukocyte responses. In our experiments, intravascular firm adherence (Figure 3C-D) and subsequent transmigration of leukocytes (Figure 3E-F) elicited by CCL3 were almost completely abolished on Ab blockade of the β2 integrins LFA-1 or Mac-1 compared with animals receiving isotype control or the nonblocking anti–PECAM-1 mAb “clone390,” whereas leukocyte rolling remained unaffected (Figure 3A-B). It is noteworthy that blockade of their putative counter receptor ICAM-1 nearly abolished intravascular firm adherence and transmigration of leukocytes and significantly enhanced the number of rolling leukocytes. In contrast, blockade of α4 integrins only slightly attenuated CCL3-elicited leukocyte responses, while blockade of its putative counter receptor VCAM-1 significantly diminished intravascular adherence and subsequent transmigration of leukocytes. Finally, blockade of PECAM-1 or of ICAM-2 selectively reduced transmigration of leukocytes on stimulation with CCL3 without affecting intravascular rolling or firm adherence of leukocytes.

Figure 3

Role of β2 and α4 integrins as well as PECAM-1, ICAM-1, ICAM-2, and VCAM-1 for CCL3-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against LFA-1, Mac-1, α4 integrins, PECAM-1 (clone Mec13.3), ICAM-1, ICAM-2, and VCAM-1 or isotype control and a nonblocking anti-PECAM-1 mAb (clone 390) after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Figure 3

Role of β2 and α4 integrins as well as PECAM-1, ICAM-1, ICAM-2, and VCAM-1 for CCL3-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against LFA-1, Mac-1, α4 integrins, PECAM-1 (clone Mec13.3), ICAM-1, ICAM-2, and VCAM-1 or isotype control and a nonblocking anti-PECAM-1 mAb (clone 390) after stimulation with CCL3 (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Close modal

Role of G protein–receptor coupling and PI3K activation for CXCL1- or PAF-elicited leukocyte responses

In further experiments, the mechanisms underlying neutrophil responses elicited by canonical neutrophil attractants were analyzed. On stimulation with the C-X-C motif chemokine CXCL1 or with the lipid mediator PAF, application of PTx only partially reduced intravascular adherence (Figure 4B) and (subsequent) transmigration of leukocytes (Figure 4C), while leukocyte rolling remained unaltered (Figure 4A). In addition, CXCL1-elicited intravascular adherence of leukocytes was only slightly attenuated in animals treated with the pan-PI3K inhibitor or the specific PI3Kγ inhibitor, but not with the PI3Kδ inhibitor, while leukocyte rolling and transmigration in response to CXCL1 were not significantly altered on treatment with the PI3K inhibitors (Figure 4D-F). Moreover, treatment with the pan-PI3K inhibitor, but not with the PI3Kγ or PI3Kδ inhibitor significantly reduced PAF-elicited leukocyte responses (Figure 4G-I).

Figure 4

Role of G protein–receptor coupling and PI3K for CXCL1- and PAF-elicited leukocyte responses. (A,D,G) Leukocyte rolling, (B,E,H) firm adherence, and (C,F,I) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving PTx, the PI3K inhibitors PI103 (pan-PI3K), AS605240 (PI3Kγ), and IC87114 (PI3Kδ), or respective vehicle after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs vehicle).

Figure 4

Role of G protein–receptor coupling and PI3K for CXCL1- and PAF-elicited leukocyte responses. (A,D,G) Leukocyte rolling, (B,E,H) firm adherence, and (C,F,I) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving PTx, the PI3K inhibitors PI103 (pan-PI3K), AS605240 (PI3Kγ), and IC87114 (PI3Kδ), or respective vehicle after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs vehicle).

Close modal

Role of β2 and α4 integrins as well as of ICAM-1, ICAM-2, VCAM-1, and PECAM-1 in CXCL1- or PAF-elicited leukocyte responses

On stimulation with CXCL1 (Figures 5A,C,E and 6A,C,E) or PAF (Figures 5B,D,F and 6B,D,F), intravascular firm adherence and subsequent transmigration of leukocytes were almost completely abolished on Ab blockade of the β2 integrins Mac-1 or LFA-1 compared with animals receiving isotype control or the nonblocking anti–PECAM-1 mAb “clone390,” whereas leukocyte rolling remained unchanged in these experiments. Interestingly, on stimulation with CXCL1 or PAF, blockade of ICAM-1 also almost completely abrogated firm adherence and transmigration of leukocytes, while only in PAF-elicited inflammation the number of rolling leukocytes was additionally enhanced. Furthermore, blockade of α4 integrins (α4β1 integrin/VLA-4 and/or α4β7 integrin) or of their putative counter receptor VCAM-1 attenuated CXCL1- and PAF-elicited leukocyte responses. Finally, blockade of PECAM-1 partially reduced intravascular adherence and transmigration of leukocytes on stimulation with CXCL1, but not in response to PAF. Interestingly, blockade of ICAM-2 significantly diminished intravascular firm adherence of leukocytes elicited by CXCL1 or PAF, but did not significantly alter leukocyte transmigration to the inflamed tissue.

Figure 5

Role of Mac-1, α4 integrins, and ICAM-1 for CXCL1- or PAF-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against Mac-1, α4 integrins, ICAM-1, or isotype control after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Figure 5

Role of Mac-1, α4 integrins, and ICAM-1 for CXCL1- or PAF-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against Mac-1, α4 integrins, ICAM-1, or isotype control after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Close modal
Figure 6

Role of LFA, PECAM-1, ICAM-2, and VCAM-1 for CXCL1- or PAF-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against LFA-1, PECAM-1 (clone Mec13.3), ICAM-2, and VCAM-1 or isotype control and a nonblocking anti–PECAM-1 mAb (clone 390) after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Figure 6

Role of LFA, PECAM-1, ICAM-2, and VCAM-1 for CXCL1- or PAF-elicited leukocyte responses. (A-B) Leukocyte rolling, (C-D) firm adherence, and (E-F) transmigration were quantified in postcapillary venules of the cremaster muscle using RLOT in vivo microscopy as detailed in “Quantification of leukocyte kinetics and microhemodynamic parameters.” Panels show results for PBS-treated WT control mice as well as for WT mice receiving blocking mAbs directed against LFA-1, PECAM-1 (clone Mec13.3), ICAM-2, and VCAM-1 or isotype control and a nonblocking anti–PECAM-1 mAb (clone 390) after stimulation with CXCL1 or PAF (mean ± SEM for n = 4 per group; #P < .05, vs unstimulated; *P < .05, vs isotype control).

Close modal

Transmigration routes of leukocytes in response to CCL3, CXCL1, or PAF

Transmigration of leukocytes occurs via the paracellular or the transcellular transmigration route. To characterize the transmigration route of extravasating leukocytes in CCL3-, CXCL1-, or PAF-elicited inflammation, endothelial boundaries in postcapillary venules of the cremaster muscle were visualized by fluorescence in vivo microscopy and, concomitantly, the localization of firmly arrested leukocytes was traced by using near-infrared RLOT in vivo microscopy (Figure 7A). Three hours after intrascrotal injection of CCL3 (90.8% ± 5.7%), CXCL1 (93.3% ± 4.2%), or PAF (94.2% ± 1.8%), firmly adherent leukocytes predominantly colocalized with PECAM-1–immunoreactive endothelial junctions (Figure 7B).

Figure 7

Transmigration routes in CCL3-, CXCL1-, and PAF-elicited leukocyte responses. (A) Representative in vivo microscopy image of a postcapillary venule in the inflamed cremaster muscle, immunostained for PECAM-1 (scale bars: 20 μm). Arrow indicates a firmly adherent leukocyte colocalizing with PECAM-1–immunoreactive endothelial junctions (green). (B) Results for the relative localization of firmly adherent leukocytes to PECAM-1–immunoreactive endothelial junctions in postcapillary venules of WT mice undergoing stimulation with CCL3, CXCL1, or PAF (mean ± SEM for n = 3 per group).

Figure 7

Transmigration routes in CCL3-, CXCL1-, and PAF-elicited leukocyte responses. (A) Representative in vivo microscopy image of a postcapillary venule in the inflamed cremaster muscle, immunostained for PECAM-1 (scale bars: 20 μm). Arrow indicates a firmly adherent leukocyte colocalizing with PECAM-1–immunoreactive endothelial junctions (green). (B) Results for the relative localization of firmly adherent leukocytes to PECAM-1–immunoreactive endothelial junctions in postcapillary venules of WT mice undergoing stimulation with CCL3, CXCL1, or PAF (mean ± SEM for n = 3 per group).

Close modal

Phenotyping of transmigrated leukocytes

Phenotyping of transmigrated leukocytes was performed by immunostaining of paraffin-embedded tissue sections of the cremaster muscle. In response to CCL3, CXCL1, or PAF, > 80% of transmigrated CD45+ leukocytes were Ly-6G+ neutrophils. The remaining 10%-20% were F4/80+ monocytes/macrophages.

Effect of monocyte/macrophage depletion on CCL3-, CXCL1-, or PAF-elicited neutrophil responses

To characterize the role of monocytes/macrophages for CCL3-, CXCL1-, or PAF-elicited neutrophil responses, experiments were performed in animals receiving monocyte/macrophage-depleting clodronate liposomes. On stimulation with CCL3, CXCL1, or PAF, no significant differences in numbers of rolling, firmly adherent, or transmigrated leukocytes were detected among animals receiving clodronate liposomes or control PBS liposomes (supplemental Figure 1).

Effect of CCL3, CXCL1, or PAF on activation of endothelial cells

To further dissect the mechanisms underlying CCL3-, CXCL1-, or PAF-elicited neutrophil responses, the effect of inflammatory mediators on activation of endothelial cells was characterized. To measure endothelial cell activation, RNA expression of E-selectin was determined in cremaster muscle samples by using RT-PCR. On stimulation with CCL3, there was a strong increase in RNA expression of E-selectin (149.4% ± 15.4%) compared with PBS-treated controls. By contrast, RNA levels of E-selectin were not significantly altered on stimulation with CXCL1 (−4.3% ± 33.6%) and only slightly enhanced in response to PAF (10.0% ± 1.3%; supplemental Figure 2).

Systemic leukocyte counts and microhemodynamic parameters

To assure intergroup comparability, systemic leukocyte counts and microhemodynamic parameters including inner vessel diameter, blood flow velocity, and wall shear rate were analyzed in each experiment. No significant differences were detected among all experimental groups (supplemental Table 1).

Leukocyte migration to the site of inflammation is a key event in innate and adaptive immunity.1,,4  In this context, it is widely accepted that C-C motif chemokines, which represent 1 of the 4 major classes of chemokines, primarily govern the migration of mononuclear cells.3,5,7  It is noteworthy that this assumption appears to be no longer valid as recent studies have clearly indicated that chemokines belonging to the C-C motif subfamily do also play a crucial role for the recruitment of eosinophils,8,9  basophils,10,11  and, in particular, neutrophils.12,,,16  CCL3 binds to 2 closely related chemokine receptors designated CCR1 and CCR5. Recently, the chemokine receptors CCR1 and CCR5 have been detected on neutrophils.17,19,21,22  The relative contribution of both chemokine receptors to discrete steps of the CCL3-mediated extravasation of neutrophils is still unclear.

In a first approach, we therefore sought to evaluate the functional relevance of CCR1 and CCR5 for CCL3-dependent neutrophil responses. Using in vivo microscopy on the mouse cremaster muscle, we observed that CCL3-induced intravascular firm adherence followed by transmigration of neutrophils were significantly diminished in Ccr1- or Ccr5-deficient animals, whereas leukocyte rolling remained unaltered. Our findings extend previous studies demonstrating that deficiency/blockade of CCR1 or CCR5 was associated with reduced neutrophil recruitment in animal models of ischemia-reperfusion injury13,14,16  or in experimental aspergillosis,29  and convincingly demonstrate that both chemokine receptors play a significant role during the extravasation of neutrophils.

Interestingly, CCR1 and CCR5 are not only expressed on neutrophils and mononuclear cells as these chemokine receptors have previously been detected on the surface of resident cells (eg, endothelial cells,23,24  smooth muscle cells,25  or mast cells26,27 ). Binding of C-C motif chemokines to leukocyte chemokine receptors is supposed to elicit immediate affinity changes of surface-expressed integrins,3,5,7  while in resident cells these chemotactic cytokines are known to primarily induce the generation of further leukocyte-attracting mediators.36,37  To which extent leukocyte and nonleukocyte chemokine receptors contribute to CCL3-mediated neutrophil recruitment remained to be determined. Using a cell-transfer technique, we found that leukocyte CCR1 and nonleukocyte CCR5 mediate CCL3-elicited intravascular adherence and subsequent transmigration of neutrophils to inflamed tissue. Moreover, we show that monocytes and macrophages are not involved in CCL3-dependent neutrophil responses. Collectively, our observations point to a complex interplay between chemokine receptors CCR1 in neutrophils and CCR5 in resident cells for the regulation of CCL3-dependent neutrophil recruitment.

Inflammatory stimuli individually use specific mechanisms for the control of the single steps of the leukocyte recruitment process. Which signaling and adhesion molecules C-C motif chemokines engage for the single steps of the neutrophil recruitment process, however, has not yet been investigated. Previous in vitro data suggest that ligand binding to a chemokine receptor on the cell surface causes allosteric changes of the receptor which, in turn, activates intracellular proteins of the G-protein family. These processes subsequently allow interaction of G proteins with different target proteins.3,5,7  Here, we show that CCL3-induced intravascular adherence and subsequent transmigration of neutrophils strictly require the activation of PTx-sensitive G proteins. Of note, on stimulation with canonical neutrophil attractants such as the C-X-C motif chemokine CXCL1 or the lipid mediator PAF, treatment with PTx only partially inhibited neutrophil extravasation.

Activated G proteins interact with intracellular target proteins such as the catalytic subunit isoforms p110γ and p110δ of PI3K. These lipid kinases, in turn, produce phosphatidylinositol-3,4,5-trisphosphate (PIP3), an intracellular second messenger which is involved in a variety of cellular functions.38,39  In our experiments, we found that signaling through the catalytic subunit isoform p110γ, but not through the catalytic subunit isoform p110δ of PI3K controls CCL3-induced intravascular firm adherence and subsequent transmigration of neutrophils. Interestingly, neutrophil extravasation elicited by CXCL1 did not require PI3K, and might therefore be regulated via different signaling pathways. In contrast, PAF-elicited neutrophil recruitment was significantly attenuated on broad-spectrum blockade of PI3K, but not after specific inhibition of the catalytic subunit isoforms p110γ or p110δ. Consequently, neutrophil responses induced by PAF might primarily be regulated via PI3K catalytic subunit isoforms different from PI3Kγ or PI3Kδ (eg, by PI3Kα or PI3Kβ), which are supposed to be activated independently of G proteins.38,39  Collectively, these data lead us to the conclusion that receptor coupling of PTx-sensitive G proteins and activation of PI3Kγ are essential events for the initiation of the CCL3-elicited inflammatory response, while this signaling pathway is not critical for neutrophil recruitment mediated by the canonical neutrophil attractants CXCL1 or PAF.

Activation of neutrophils results in immediate affinity changes of surface-expressed integrins thereby regulating adhesion and migration of these inflammatory cells.1,3  Which integrins C-C motif chemokines use for the recruitment of neutrophils is still unknown. In our experiments, we observed that, particularly, the β2 integrins Mac-1 and LFA-1 as well as their putative counter receptor ICAM-1 are critically involved in the regulation of CCL3-dependent intravascular adherence and subsequent transmigration of neutrophils. Moreover, neutrophil responses elicited by CXCL1 or PAF were also found to require Mac-1, LFA-1, and ICAM-1 underlining the elementary role of these proteins for the neutrophil recruitment process. Interestingly, blockade of ICAM-1 significantly enhanced leukocyte rolling on stimulation with CCL3 or PAF, while in CXCL1-elicited inflammation, leukocyte rolling was not significantly altered on blockade of Mac-1. These observations point to a stimulus-specific control of the initial steps in the leukocyte recruitment cascade. In this context, it should be noted that at present we have no clear answer to the question of whether ICAM-1 serves as a binding partner of Mac-1 and LFA-1 under these inflammatory conditions or whether these promiscuous integrins interact with one of their multiple other ligands (eg, ICAM-2, RAGE, or components of the complement system as well as of the fibrinolytic system for Mac-1; ICAM-2, ICAM-3, or JAM-A for LFA-1) in CCL3-, CXCL1-, or PAF-elicited neutrophil responses.

Astonishingly, we found that α4 integrins (α4β1 integrin/VLA-4 and/or α4β7 integrin, which are highly expressed in lymphocytes, but only weakly in neutrophils) participate in CCL3-, CXCL1-, and PAF-induced neutrophil extravasation. Moreover, it is interesting that blockade of their putative counter receptor VCAM-1 was also associated with significantly diminished intravascular adherence and subsequent transmigration of neutrophils elicited by CCL3, CXCL1, or PAF. Our results extend previously published observations. VLA-4 has been shown to mediate neutrophil recruitment in experimental peritonitis40  or vasculitis41  and VCAM-1 has been reported to control neutrophil infiltration in a model of myocardial ischemia reperfusion (I/R).42  These data highlight a formerly neglected role of these molecules in the innate immune response.

After their adhesion to endothelial cells, leukocytes either squeeze between adjacent endothelial cells or directly penetrate endothelial cells (paracellular vs transcellular transmigration route) to enter the perivascular space.1,2  In this report, we demonstrate that on stimulation with CCL3, CXCL1, or PAF, > 90% of firmly adherent leukocytes colocalized with endothelial junctions. These observations strongly suggest that under these inflammatory conditions (CCL3-, CXCL1-, or PAF-induced) neutrophils predominantly take the paracellular transmigration route to overcome the endothelial barrier. Our data agree with previous reports as the leukocyte transmigration route was not dependent on the inflammatory stimulus applied.43,44  Moreover, we found that PECAM-1 and ICAM-2 selectively mediate CCL3-elicited transmigration of neutrophils to the inflamed tissue extending previous results under different inflammatory conditions. In this context, ICAM-2 is suggested to act in an early stage of leukocyte transmigration whereas PECAM-1 (and other molecules such as JAM-A) are thought to be involved later in this sequential process.45  Interestingly, we found that PECAM-1 was engaged in the extravasation process of neutrophils already on the level of intravascular adherence on stimulation with CXCL1 while this molecule was not required for PAF-elicited neutrophil recruitment. Furthermore, ICAM-2 was dispensable for leukocyte transmigration in response to CXCL1 or PAF. These results are in line with previous observations demonstrating that PECAM-1 and ICAM-2 facilitate leukocyte transmigration elicited by the cytokine IL-1β, but not by TNF-α.45  A possible explanation for the stimulus-specific control of leukocyte recruitment might be that individual inflammatory mediators differentially activate distinct target cell populations involved in the leukocyte extravasation process thereby engaging different molecular mechanisms: while nonleukocyte cells (eg, endothelial cells, mast cells) strongly respond to stimulation with C-C motif chemokines, canonical neutrophil attractants such as C-X-C motif chemokines and lipid mediators serve as potent activators of neutrophils.37  From this perspective, the entirety of our experimental data also reveals that C-C motif chemokines, C-X-C motif chemokines, and lipid mediators exhibit both common and distinct mechanisms for the regulation of the neutrophil recruitment process.

In conclusion, our in vivo findings demonstrate that both CCR1 and CCR5 are critically involved in CCL3-dependent intravascular firm adherence and subsequent paracellular transmigration of neutrophils. In this context, leukocyte CCR1 and nonleukocyte CCR5 are engaged, initiating intracellular signal transduction through G protein–receptor coupling and activation of PI3Kγ. Subsequently, intravascular adherence is particularly mediated by the β2 integrins LFA-1 and Mac-1, to a lesser degree by α4 integrins as well as by their putative counter receptors ICAM-1 and VCAM-1, whereas paracellular transmigration of neutrophils is facilitated through PECAM-1 and ICAM-2. These findings corroborate the significance of C-C motif chemokines for neutrophil recruitment, provide a rationale of how these inflammatory mediators exert their effects, and identify these chemotactic cytokines as well as their receptors as potential therapeutic targets for the treatment of neutrophil-driven inflammatory diseases.

The online version of this article contains a data supplement.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.

The authors thank A. Schropp and G. Adams for technical assistance. Data presented in this manuscript are part of the doctoral thesis of D.P.-W.

This work was supported by Deutsche Forschungsgemeinschaft (DFG; RE 2885-1/1 [C.A.R.]; LU612/4-3 [B.L.]; SFB 914 [C.A.R., F.K.]) and Friedrich-Baur-Stiftung (C.A.R.).

Contribution: C.A.R. designed and performed experiments, and contributed to data analysis, interpretation, and the writing of the manuscript; D.P.-W., G.Z., B.U., N.B., and S.Z. performed experiments and contributed to data analysis, interpretation, and the writing of the manuscript; M.P.W. and B.L. provided key reagents and contributed to data analysis, interpretation, and the writing of the manuscript; and F.K. contributed to data analysis, interpretation, and the writing of the manuscript.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Dr Christoph A. Reichel, Walter Brendel Centre of Experimental Medicine, Marchioninistr 15, D-81366 München, Germany; e-mail: christoph.reichel@med.uni-muenchen.de.

1
Nourshargh
S
Hordijk
PL
Sixt
M
Breaching multiple barriers: leukocyte motility through venular walls and the interstitium.
Nat Rev Mol Cell Biol
2010
11
5
366
378
2
Ley
K
Laudanna
C
Cybulsky
MI
Nourshargh
S
Getting to the site of inflammation: the leukocyte adhesion cascade updated.
Nat Rev Immunol
2007
7
9
678
689
3
Weber
C
Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules.
J Mol Med
2003
81
1
4
19
4
Phillipson
M
Kubes
P
The neutrophil in vascular inflammation.
Nat Med
2011
17
11
1381
1390
5
Viola
A
Luster
AD
Chemokines and their receptors: drug targets in immunity and inflammation.
Annu Rev Pharmacol Toxicol
2008
48
171
197
6
Charo
IF
Ransohoff
RM
The many roles of chemokines and chemokine receptors in inflammation.
N Engl J Med
2006
354
6
610
621
7
Rot
A
von Andrian
UH
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.
Annu Rev Immunol
2004
22
891
928
8
Lukacs
NW
Strieter
RM
Warmington
K
et al
Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation.
J Immunol
1997
158
9
4398
4404
9
Rot
A
Krieger
M
Brunner
T
et al
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
J Exp Med
1992
176
6
1489
1495
10
Iikura
M
Ebisawa
M
Yamaguchi
M
et al
Transendothelial migration of human basophils.
J Immunol
2004
173
8
5189
5195
11
Heinemann
A
Hartnell
A
Stubbs
VE
et al
Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling.
J Immunol
2000
165
12
7224
7233
12
Drechsler
M
Megens
RT
van Zandvoort
M
Weber
C
Soehnlein
O
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.
Circulation
2010
122
18
1837
1845
13
Reichel
CA
Khandoga
A
Anders
HJ
et al
Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue.
J Leukoc Biol
2006
79
1
114
122
14
Krishnadasan
B
Farivar
AS
Naidu
BV
et al
Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Ann Thorac Surg
2004
77
3
1056
1062
15
Standiford
TJ
Kunkel
SL
Lukacs
NW
et al
Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia.
J Immunol
1995
155
3
1515
1524
16
Furuichi
K
Gao
JL
Horuk
R
et al
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.
J Immunol
2008
181
12
8670
8676
17
Cheng
SS
Lai
JJ
Lukacs
NW
Kunkel
SL
Granulocyte-macrophage colony stimulating factor up-regulates CCR1 in human neutrophils.
J Immunol
2001
166
2
1178
1184
18
Iida
S
Kohro
T
Kodama
T
Nagata
S
Fukunaga
R
Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation.
J Leukoc Biol
2005
78
2
481
490
19
Ottonello
L
Montecucco
F
Bertolotto
M
et al
CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2.
Cell Signal
2005
17
3
355
363
20
Johnston
B
Burns
AR
Suematsu
M
et al
Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.
J Clin Invest
1999
103
9
1269
1276
21
Hartl
D
Krauss-Etschmann
S
Koller
B
et al
Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases.
J Immunol
2008
181
11
8053
8067
22
Speyer
CL
Gao
H
Rancilio
NJ
et al
Novel chemokine responsiveness and mobilization of neutrophils during sepsis.
Am J Pathol
2004
165
6
2187
2196
23
Edinger
AL
Mankowski
JL
Doranz
BJ
et al
CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain.
Proc Natl Acad Sci U S A
1997
94
26
14742
14747
24
Hwang
J
Son
KN
Kim
CW
et al
Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.
Cytokine
2005
30
5
254
263
25
Edinger
AL
Amedee
A
Miller
K
et al
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.
Proc Natl Acad Sci U S A
1997
94
8
4005
4010
26
Alam
R
Kumar
D
Anderson-Walters
D
Forsythe
PA
Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo.
J Immunol
1994
152
3
1298
1303
27
Oliveira
SH
Lukacs
NW
Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors.
Inflamm Res
2001
50
3
168
174
28
Luckow
B
Joergensen
J
Chilla
S
et al
Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.
Eur J Immunol
2004
34
9
2568
2578
29
Gao
JL
Wynn
TA
Chang
Y
et al
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.
J Exp Med
1997
185
11
1959
1968
30
Baez
S
An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.
Microvasc Res
1973
5
3
384
394
31
Mempel
TR
Moser
C
Hutter
J
et al
Visualization of leukocyte transendothelial and interstitial migration using reflected light oblique transillumination in intravital video microscopy.
J Vasc Res
2003
40
5
435
441
32
Reichel
CA
Uhl
B
Lerchenberger
M
et al
Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.
Circulation
2011
124
17
1848
1859
33
Woodfin
A
Reichel
CA
Khandoga
A
et al
JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration.
Blood
2007
110
6
1848
1856
34
Kreisel
D
Nava
RG
Li
W
et al
In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation.
Proc Natl Acad Sci U S A
2010
107
42
18073
18078
35
Van
RN
Sanders
A
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.
J Immunol Methods
1994
174
83
93
36
Ramos
CD
Canetti
C
Souto
JT
et al
MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
J Leukoc Biol
2005
78
1
167
177
37
Reichel
CA
Rehberg
M
Lerchenberger
M
et al
Ccl2 and Ccl3 mediate neutrophil recruitment via induction of protein synthesis and generation of lipid mediators.
Arterioscler Thromb Vasc Biol
2009
29
11
1787
1793
38
Marone
R
Cmiljanovic
V
Giese
B
et al
Targeting phosphoinositide 3-kinase: moving towards therapy.
Biochim Biophys Acta
2008
1784
1
159
185
39
Morello
F
Perino
A
Hirsch
E
Phosphoinositide 3-kinase signalling in the vascular system.
Cardiovasc Res
2009
82
2
261
271
40
Henderson
RB
Lim
LH
Tessier
PA
et al
The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils.
J Exp Med
2001
194
2
219
226
41
Kuligowski
MP
Kwan
RY
Lo
C
et al
Antimyeloperoxidase antibodies rapidly induce alpha-4-integrin-dependent glomerular neutrophil adhesion.
Blood
2009
113
25
6485
6494
42
Bowden
RA
Ding
ZM
Donnachie
EM
et al
Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium.
Circ Res
2002
90
5
562
569
43
Schulte
D
Kuppers
V
Dartsch
N
et al
Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability.
EMBO J
2011
30
20
4157
4170
44
Woodfin
A
Voisin
MB
Beyrau
M
et al
The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo.
Nat Immunol
2011
12
8
761
769
45
Woodfin
A
Voisin
MB
Imhof
BA
et al
Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1.
Blood
2009
113
24
6246
6257
Sign in via your Institution